Verenium Outlines Commercial Launch of Pyrolase HT Product

Verenium Corporation

, a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced the commercial launch of Pyrolase^® HT cellulase, a next-generation cellulase enzyme for use as a biocatalyst to break down the guar-based gel used in hydraulic fracturing.  (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) Pyrolase^® HT is a highly thermo-stable enzyme developed by Verenium scientists using proprietary DirectEvolution^® technology to meet more demanding performance requirements and expand the addressable market that can be serviced by its product line. In July 2012, Verenium announced that the Company had received regulatory authorization from the Environmental Protection Agency (EPA) to market Pyrolase^® HT cellulase.  In laboratory evaluations conducted by several oilfield service companies, it has demonstrated that it functions well in more extreme temperature ranges and higher pH conditions.